Société de Therapeutique Marocaine S.A. (CBSE:SOT)
Morocco · Delayed Price · Currency is MAD 362.00
0.00 (0.00%)
At close: Sep 18, 2026
CBSE:SOT Ratios and Metrics
Market cap in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,868 | 14,072 | 6,660 | 6,847 | 9,504 | 10,656 | |
Market Cap Growth | -0.20% | 111.30% | -2.73% | -27.96% | -10.81% | 196.00% |
Enterprise Value | 14,726 | 14,410 | 7,163 | 7,192 | 9,684 | 10,852 |
Last Close Price | 362.00 | 363.44 | 178.10 | 180.08 | 244.57 | 269.49 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 35.71 | 36.50 | 21.12 | 26.06 | 35.65 | 38.21 |
Forward PE | - | 35.51 | 22.56 | 37.01 | 40.74 | 45.68 |
PS Ratio | 4.30 | 4.36 | 2.37 | 2.75 | 4.13 | 5.18 |
PB Ratio | 5.23 | 5.31 | 3.90 | 4.51 | 6.63 | 8.26 |
P/TBV Ratio | 8.81 | 8.94 | 4.09 | 4.75 | 7.00 | 8.65 |
P/FCF Ratio | 36.26 | 36.80 | 55.07 | - | 110.09 | 40.19 |
P/OCF Ratio | 30.10 | 30.55 | 28.50 | 68.51 | 60.75 | 32.52 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.57 | 4.47 | 2.54 | 2.89 | 4.21 | 5.28 |
EV/EBITDA Ratio | 18.76 | 18.77 | 11.40 | 16.00 | 17.94 | 21.11 |
EV/EBIT Ratio | 20.28 | 19.81 | 12.78 | 18.21 | 20.06 | 23.62 |
EV/FCF Ratio | 38.51 | 37.68 | 59.23 | - | 112.17 | 40.93 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.37 | 0.37 | 0.35 | 0.33 | 0.25 | 0.17 |
Debt / EBITDA Ratio | 1.24 | 1.24 | 0.94 | 1.12 | 0.65 | 0.44 |
Debt / FCF Ratio | 2.55 | 2.55 | 4.87 | - | 4.08 | 0.84 |
Net Debt / Equity Ratio | 0.31 | 0.31 | 0.30 | 0.30 | 0.21 | 0.11 |
Net Debt / EBITDA Ratio | 1.08 | 1.08 | 0.81 | 1.00 | 0.56 | 0.26 |
Net Debt / FCF Ratio | 2.17 | 2.17 | 4.23 | -25.31 | 3.50 | 0.51 |
Asset Turnover | 0.83 | 0.83 | 0.95 | 0.95 | 1.00 | 0.99 |
Inventory Turnover | 1.69 | 1.69 | 1.72 | 1.77 | 1.88 | 1.80 |
Quick Ratio | 0.96 | 0.96 | 1.04 | 1.02 | 1.00 | 1.00 |
Current Ratio | 1.76 | 1.76 | 1.86 | 1.87 | 1.89 | 1.83 |
Return on Equity (ROE) | 17.82% | 17.82% | 19.67% | 17.87% | 19.62% | 22.32% |
Return on Assets (ROA) | 11.67% | 11.67% | 11.82% | 9.46% | 13.12% | 13.84% |
Return on Invested Capital (ROIC) | 13.01% | 15.89% | 17.25% | 14.52% | 19.56% | 21.47% |
Return on Capital Employed (ROCE) | 22.70% | 22.70% | 27.90% | 22.20% | 29.00% | 32.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.78% | 2.74% | 4.73% | 3.84% | 2.80% | 2.62% |
FCF Yield | 2.76% | 2.72% | 1.82% | -0.26% | 0.91% | 2.49% |
Dividend Yield | 1.82% | 1.82% | 3.14% | 1.89% | 2.04% | 1.85% |
Payout Ratio | 52.29% | 52.29% | 38.82% | 68.50% | 67.51% | 54.22% |
Buyback Yield / Dilution | -5.65% | -5.65% | - | - | - | - |
Total Shareholder Return | -3.83% | -3.83% | 3.14% | 1.89% | 2.04% | 1.85% |